These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 23150189)

  • 1. Power of metabolomics in diagnosis and biomarker discovery of hepatocellular carcinoma.
    Wang X; Zhang A; Sun H
    Hepatology; 2013 May; 57(5):2072-7. PubMed ID: 23150189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular carcinoma: diagnostics and screening.
    Patel M; Shariff MI; Ladep NG; Thillainayagam AV; Thomas HC; Khan SA; Taylor-Robinson SD
    J Eval Clin Pract; 2012 Apr; 18(2):335-42. PubMed ID: 21114800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current advances in tumor proteomics and candidate biomarkers for hepatic cancer.
    Peng XQ; Wang F; Geng X; Zhang WM
    Expert Rev Proteomics; 2009 Oct; 6(5):551-61. PubMed ID: 19811076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabonomic profiles discriminate hepatocellular carcinoma from liver cirrhosis by ultraperformance liquid chromatography-mass spectrometry.
    Wang B; Chen D; Chen Y; Hu Z; Cao M; Xie Q; Chen Y; Xu J; Zheng S; Li L
    J Proteome Res; 2012 Feb; 11(2):1217-27. PubMed ID: 22200553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics in the diagnosis of hepatocellular carcinoma: focus on high risk hepatitis B and C patients.
    El-Aneed A; Banoub J
    Anticancer Res; 2006; 26(5A):3293-300. PubMed ID: 17094443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward the discovery of new biomarkers of hepatocellular carcinoma by proteomics.
    Santamaría E; Muñoz J; Fernández-Irigoyen J; Prìeto J; Corrales FJ
    Liver Int; 2007 Mar; 27(2):163-73. PubMed ID: 17311610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel molecular targets for diagnosis and treatment of hepatocellular carcinoma.
    Ma L; Ji L; Yu Y; Wang J
    Discov Med; 2015 Jan; 19(102):7-14. PubMed ID: 25636956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dimensional biology to comprehend hepatocellular carcinoma.
    Vivekanandan P; Singh OV
    Expert Rev Proteomics; 2008 Feb; 5(1):45-60. PubMed ID: 18282123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular signature of early hepatocellular carcinoma.
    Suriawinata A; Thung SN
    Oncology; 2010 Jul; 78 Suppl 1():36-9. PubMed ID: 20616582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of hepatocellular carcinoma: role of tumor markers and liver biopsy.
    Gonzalez SA; Keeffe EB
    Clin Liver Dis; 2011 May; 15(2):297-306, vii-x. PubMed ID: 21689614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in tumor markers of human hepatocellular carcinoma.
    Yoon SK
    Intervirology; 2008; 51 Suppl 1():34-41. PubMed ID: 18544946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic Characterization Analysis of Human Hepatocarcinoma by Urine Metabolomics Approach.
    Liang Q; Liu H; Wang C; Li B
    Sci Rep; 2016 Jan; 6():19763. PubMed ID: 26805550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and prognostic value of alpha-fetoprotein, des-γ-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma.
    Bertino G; Neri S; Bruno CM; Ardiri AM; Calvagno GS; Malaguarnera M; Toro A; Malaguarnera M; Clementi S; Bertino N; Di Carlo I
    Minerva Med; 2011 Oct; 102(5):363-71. PubMed ID: 22193346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candidate molecular markers for histological diagnosis of early hepatocellular carcinoma.
    Sakamoto M; Mori T; Masugi Y; Effendi K; Rie I; Du W
    Intervirology; 2008; 51 Suppl 1():42-5. PubMed ID: 18544947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum markers of hepatocellular carcinoma.
    Spangenberg HC; Thimme R; Blum HE
    Semin Liver Dis; 2006 Nov; 26(4):385-90. PubMed ID: 17051452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics.
    Shariff MI; Cox IJ; Gomaa AI; Khan SA; Gedroyc W; Taylor-Robinson SD
    Expert Rev Gastroenterol Hepatol; 2009 Aug; 3(4):353-67. PubMed ID: 19673623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 70-year-old woman with 10 years of markedly elevated alpha-fetoprotein measurements.
    Hsu SX; Siegel AB; Berk PD
    Semin Liver Dis; 2010 Feb; 30(1):99-106. PubMed ID: 20175037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of lamin B1 and vimentin as circulating biomarkers for early hepatocellular carcinoma.
    Wong KF; Luk JM
    Methods Mol Biol; 2012; 909():295-310. PubMed ID: 22903723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tumor markers for hepatocellular carcinoma].
    Fujiyama S; Tanaka M; Maeda S; Ashihara H; Hirata R
    Gan To Kagaku Ryoho; 2001 May; 28(5):723-32. PubMed ID: 11383225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Power of metabolomics in biomarker discovery and mining mechanisms of obesity.
    Zhang A; Sun H; Wang X
    Obes Rev; 2013 Apr; 14(4):344-9. PubMed ID: 23279162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.